Dr Adam Sharp Seminar
"Targeting the intrinsic apoptosis pathway in lethal prostate cancer"
We are delighted to invite you to an upcoming lecture by Dr. Adam Sharp, a distinguished clinician scientist from the Institute of Cancer Research in London, who will be visiting us in Manchester on November 21, 2024. Dr. Sharp is highly regarded for his groundbreaking research into novel therapeutic strategies for prostate cancer, and we are thrilled to host him for what promises to be an enlightening session.
Talk Title: Targeting the intrinsic apoptosis pathway in lethal prostate cancer
Date
21/11/2024 – 21/11/2024
Time
10:00 am – 11:00 am
About Dr Adam Sharp
Dr Adam Sharp is Leader of the Translational Therapeutics Group and Honorary Consultant Medical Oncologist within the Prostate Cancer Targeted Therapies Group and Drug Development Unit at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.
Dr Sharp is focussed on developing novel therapeutic strategies (from bench to bedside) for the treatment of advanced prostate cancer and he has published and presented work within this field.
His work has been recognised with research awards from the Royal Society of Medicine, Academy of Medical Sciences and American Society of Clinical Oncology. Most recently he has been awarded a Prostate Cancer Foundation Young Investigator Award and Wellcome Trust Clinical Research Career Development Fellowship.
The work of his group is focused on identifying novel therapeutic strategies to prevent the development of treatment resistance and to overcome the progression of cancer.
Find out more about Adam and his research on the ICR website.
There are currently no plans to record the event. Please email MCRCComms@manchester.ac.uk if you wish to enquire about the event recording.
No the event will be in person only. This is to give the speaker and attendees the best experience of a lecture in Manchester and lead to an engaging question and answer session.